Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity

v3.21.2
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Balance at the beginning at Jun. 30, 2019 $ 16,594 $ 0 $ 127,328 $ (108,870) $ (1,864)
Balance at the beginning (In shares) at Jun. 30, 2019   856,765      
Common stock sold for cash, net of issuance costs 1,720   1,720    
Common stock sold for cash, net of issuance costs, Shares   186,666      
Issuance and exercise of pre-funded warrants, net of transaction costs of $240 50   50    
Issuance and exercise of pre-funded warrants, net of transaction costs of $240, Shares   27,526      
Cashless exercise of purchase warrants (In shares)   37,417      
Share-based compensation 237   237    
Forfeiture of share-based payments     (508) 508  
Foreign currency translation loss (Gain) (89)       (89)
Net loss (8,274)     (8,274)  
Balance at end at Jun. 30, 2020 10,238 $ 0 128,827 (116,636) (1,953)
Balance at end (In shares) at Jun. 30, 2020   1,108,374      
Common stock sold for cash, net of issuance costs 22,519 $ 1 22,518    
Common stock sold for cash, net of issuance costs, Shares   6,504,154      
Cashless exercise of purchase warrants (In shares)   37,417      
Exercise of pre-funded warrants, Shares   559,162      
Exercise of pre-funded warrants 3   3    
Share-based compensation 634   634    
Forfeiture of share-based payments     (399) 399  
Foreign currency translation loss (Gain) 498       498
Net loss (13,882)     (13,882)  
Balance at end at Jun. 30, 2021 $ 20,010 $ 1 $ 151,583 $ (130,119) $ (1,455)
Balance at end (In shares) at Jun. 30, 2021   8,171,690